BASAL CELL CARCINOMA

This study observed how well the immunotherapy drug cemiplimab worked for patients with advanced forms of two common skin cancers (squamous cell and basal cell carcinoma) in real-world clinics, not just in a controlled trial. It tracked 287 patients to see how their tumors respon…

This study tested an experimental drug called cemiplimab, injected directly into skin cancer tumors before surgery. The main goal was to see if this approach was safe and how well patients tolerated it. Researchers also looked at whether the injections could shrink the tumors.

This small, early-stage study tested a new radiation patch called CivaDerm for treating common skin cancers like basal cell and squamous cell carcinoma. The patch uses a radioactive material (palladium-103) in a new design to deliver radiation directly to the skin's surface. The …

This study aimed to collect real-world safety information on the drug Odomzo (sonidegib) for patients with advanced basal cell carcinoma who cannot have surgery or radiation. Researchers followed 323 adult patients for up to three years in a routine clinical setting to document s…

This study tested a new approach for people with basal cell carcinoma (a common skin cancer) in sensitive areas like the face. Patients took a daily pill called sonidegib for 12 weeks before surgery. The goal was to shrink the tumor so the surgery would be smaller, cause less sca…

This study tested a new type of microscope called two-photon microscopy to see if it could accurately check for leftover cancer cells during Mohs surgery for basal cell carcinoma. Researchers compared the microscope's results to the standard frozen section analysis method in 135 …

This study tested whether telling people about their genetic risk for skin cancer would change their sun safety habits. Over 2,000 adults, including Hispanic and non-Hispanic white participants, provided a saliva sample for genetic testing. Researchers then measured if receiving …